“…Among the remaining 99 articles, 26 were excluded from the final analysis because they met at least one exclusion criterion: (i) six NLPHL/NHL composite lymphomas without cHL contingent [ 27 , 28 , 29 , 30 , 31 , 32 ]; (ii) two cHL with an Epstein–Barr virus (EBV) post-transplant lymphoproliferative disorder [ 33 ] or EBV mucocutaneous ulcer [ 34 ]; (iii) one with CD30 negative Hodgkin cells [ 35 ]; (iv) four with Hodgkin-like cells within an NHL [ 36 , 37 , 38 , 39 ]; (v) two sequential lymphomas [ 40 , 41 ]; (vi) ten probable transformations of CCL into cHL [ 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 ]; and (vii) one because the final diagnosis could be considered ambiguous [ 52 ].…”